Department of Central Laboratory, Songjiang Hospital Affiliated First People's Hospital, Shanghai Jiao Tong University, 746 Zhongshan Road, Shanghai, 201600, China.
Department of Laboratory Medicine, Tongji Hospital of Tongji University School of Medicine, 389 Xincun Road, Shanghai, 200065, China.
J Cancer Res Clin Oncol. 2020 May;146(5):1103-1113. doi: 10.1007/s00432-020-03174-1. Epub 2020 Mar 10.
Microtubule-associated protein 1 light chain 3 (LC3), an autophagic gene, has been reported as a vital marker for many diseases and cancers. However, the role of LC3 in hepatocellular carcinoma (HCC) was not still investigated. Therefore, we conducted a meta-analysis to examine the association of LC3 with its clinicopathological and prognostic in HCC.
We consulted the PubMed, Cochrane Library, Web of Science, EMBASE, China National Knowledge Infrastructure and Wan Fang databases for published studies on LC3 in HCC. Newcastle-Ottawa scale was used to screen the quality of the literature. The statistical analysis was calculated by STATA 14.2.
Of the 1329 titles identified, 10 articles involving 949 patients in HCC were included in this meta-analysis. The results of our study show that increased LC3 expression is related to size of tumor, but not to gender, age, number of tumor, liver cirrhosis, HBsAg, TNM stage, alpha fetoprotein, vascular invasion and histological grade. Positive LC3 expression was associated with overall survival by pooled hazard ratio.
This meta-analysis indicated that positive LC3 expression was related to size of tumor, and could predict prognosis in human hepatocellular carcinoma.
微管相关蛋白 1 轻链 3(LC3)是一种自噬基因,已被报道为许多疾病和癌症的重要标志物。然而,LC3 在肝细胞癌(HCC)中的作用尚未得到研究。因此,我们进行了一项荟萃分析,以研究 LC3 与 HCC 的临床病理和预后之间的关系。
我们检索了 PubMed、Cochrane 图书馆、Web of Science、EMBASE、中国国家知识基础设施和万方数据库中关于 LC3 在 HCC 中的研究。使用 Newcastle-Ottawa 量表筛选文献质量。统计分析使用 STATA 14.2 进行计算。
在 1329 个标题中,有 10 篇涉及 HCC 中 949 例患者的文章被纳入本荟萃分析。我们的研究结果表明,LC3 表达增加与肿瘤大小有关,但与性别、年龄、肿瘤数量、肝硬化、HBsAg、TNM 分期、甲胎蛋白、血管侵犯和组织学分级无关。LC3 阳性表达的患者总生存风险比(HR)更高。
本荟萃分析表明,LC3 阳性表达与肿瘤大小有关,并可预测人类肝细胞癌的预后。